Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2994)
All Articles published online
|
Aug 7, 2009 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Weekes J, Lam AKY, Sebesan S, Ho YH. Irinotecan therapy and molecular targets in colorectal cancer: A systemic review. World J Gastroenterol 2009; 15(29): 3597-3602 [PMID: 19653336 DOI: 10.3748/wjg.15.3597] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i29/3597.htm |
| Number | Citing Articles |
| 1 |
Moriah Wright, Jenifer S. Beaty, Charles A. Ternent. Molecular Markers for Colorectal Cancer. Surgical Clinics of North America 2017; 97(3): 683 doi: 10.1016/j.suc.2017.01.014
|
| 2 |
Yong-E. Gao, Shuang Bai, Xiaoxiao Shi, Meili Hou, Xiaoqian Ma, Tian Zhang, Bo Xiao, Peng Xue, Yuejun Kang, Zhigang Xu. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy. Colloids and Surfaces B: Biointerfaces 2018; 170: 488 doi: 10.1016/j.colsurfb.2018.06.054
|
| 3 |
YU GU, SHEN-LIN LIU, WEN-ZHENG JU, CHANG-YIN LI, PENG CAO. Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cells. Oncology Letters 2013; 5(2): 483 doi: 10.3892/ol.2012.1049
|
| 4 |
Shoichi Matsukuma, Haruhiro Saito, Kozo Yamada, Naoyuki Okamoto, Tomokazu Ishikawa, Mitsuyo Yoshihara, Shiro Koizume, Yuji Sakuma, Yohei Miyagi. Simple and precise detection of UGT1A1 polymorphisms with a modified loop-hybrid mobility shift assay using Cy5-labeled loop probes. Clinica Chimica Acta 2011; 412(17-18): 1668 doi: 10.1016/j.cca.2011.05.021
|
| 5 |
Jeffrey S Ross. Biomarker-Based Selection of Therapy For Colorectal Cancer. Biomarkers in Medicine 2011; 5(3): 319 doi: 10.2217/bmm.11.38
|
| 6 |
Rachel M. McQuade, Vanesa Stojanovska, Elizabeth L. Donald, Ahmed A. Rahman, Dean G. Campelj, Raquel Abalo, Emma Rybalka, Joel C. Bornstein, Kulmira Nurgali. Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons. Frontiers in Physiology 2017; 8 doi: 10.3389/fphys.2017.00391
|
| 7 |
Yu Zhang, Hongyu Zhang, Pan He, Xuan Yi, Xinming Liu, Chunsheng Xiao. A PEGylated alternating copolymeric prodrug of sulfur dioxide with glutathione responsiveness for Irinotecan delivery. Journal of Materials Chemistry B 2021; 9(1): 187 doi: 10.1039/D0TB02097D
|
| 8 |
Maria Rosaria di Nunzio, Yasmin Douhal, Juan Angel Organero, Abderrazzak Douhal. Structural and photodynamic properties of the anti-cancer drug irinotecan in aqueous solutions of different pHs. Physical Chemistry Chemical Physics 2018; 20(20): 14182 doi: 10.1039/C8CP01134F
|
| 9 |
Jiafeng Tong, Ying Shen, Zhenghua Zhang, Ye Hu, Xu Zhang, Li Han. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway. Bioscience Reports 2019; 39(5) doi: 10.1042/BSR20190452
|
| 10 |
Ivo Doskočil, Anna Hošťálková, Marcela Šafratová, Nina Benešová, Jaroslav Havlík, Radim Havelek, Jiří Kuneš, Karel Královec, Jakub Chlebek, Lucie Cahlíková. Cytotoxic activities of Amaryllidaceae alkaloids against gastrointestinal cancer cells. Phytochemistry Letters 2015; 13: 394 doi: 10.1016/j.phytol.2015.08.004
|
| 11 |
Jeffrey S. Ross, Jorge Torres-Mora, Nikhil Wagle, Timothy A. Jennings, David M. Jones. Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer. American Journal of Clinical Pathology 2010; 134(3): 478 doi: 10.1309/AJCP2Y8KTDPOAORH
|
| 12 |
Émilie C. Lefort, Jonathan Blay. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. Clinical & Experimental Metastasis 2011; 28(4): 337 doi: 10.1007/s10585-010-9364-6
|
| 13 |
Hossieny Ibrahim, Yassien Temerk. Gold nanoparticles anchored graphitized carbon nanofibers ionic liquid electrode for ultrasensitive and selective electrochemical sensing of anticancer drug irinotecan. Microchimica Acta 2020; 187(10) doi: 10.1007/s00604-020-04560-9
|
| 14 |
Xing He, Huanrong Lan, Ketao Jin, Fanlong Liu. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1237764
|
| 15 |
Diana C. DeLucia, Thomas M. Cardillo, Lisa Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins, Navonil De Sarkar, Ilsa Coleman, Rui M. Gil da Costa, Eva Corey, Lawrence D. True, Michael C. Haffner, Michael T. Schweizer, Colm Morrissey, Peter S. Nelson, John K. Lee. Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer. Clinical Cancer Research 2021; 27(3): 759 doi: 10.1158/1078-0432.CCR-20-3396
|
| 16 |
Anna Chruścik, Vinod Gopalan, Alfred King-yin Lam. The clinical and biological roles of transforming growth factor beta in colon cancer stem cells: A systematic review. European Journal of Cell Biology 2018; 97(1): 15 doi: 10.1016/j.ejcb.2017.11.001
|
| 17 |
Luigi Grassi, Maria Giulia Nanni, Yosuke Uchitomi, Michelle Riba. Depression and Cancer. 2010; : 151 doi: 10.1002/9780470972533.ch7
|
| 18 |
J.-M. Escoffre, A. Novell, S. Serrière, T. Lecomte, A. Bouakaz. Irinotecan Delivery by Microbubble-Assisted Ultrasound: In Vitro Validation and a Pilot Preclinical Study. Molecular Pharmaceutics 2013; 10(7): 2667 doi: 10.1021/mp400081b
|
| 19 |
Pankajini Mallick, Pranav Shah, Adarsh Gandhi, Romi Ghose. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice. Life Sciences 2015; 139: 132 doi: 10.1016/j.lfs.2015.08.017
|
| 20 |
Zhaohuan Li, Chunxi Liu, Chenglei Li, Fangqing Wang, Jianhao Liu, Zengjuan Zheng, Jingliang Wu, Bo Zhang. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01172-0
|
| 21 |
Katsuhiro Kita, Allen Burdowski. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management. World Journal of Gastroenterology 2024; 30(13): 1780-1790 doi: 10.3748/wjg.v30.i13.1780
|
| 22 |
Elisa Checa-Chavarria, Eva Rivero-Buceta, Miguel Angel Sanchez Martos, Gema Martinez Navarrete, Cristina Soto-Sánchez, Pablo Botella, Eduardo Fernández. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme. Molecular Pharmaceutics 2021; 18(4): 1558 doi: 10.1021/acs.molpharmaceut.0c00968
|
| 23 |
Xiangge Tian, Meirong Zhou, Jing Ning, Xiaopeng Deng, Lei Feng, Huilian Huang, Dahong Yao, Xiaochi Ma. The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2. Journal of Enzyme Inhibition and Medicinal Chemistry 2021; 36(1): 737 doi: 10.1080/14756366.2021.1896500
|
| 24 |
Vinod Gopalan, Robert A. Smith, Mohammad R. Nassiri, Koichi Yasuda, Ali Salajegheh, Sang Y. Kim, Yik-Hong Ho, Stephen Weinstein, Johnny C.-O. Tang, Alfred K.-Y. Lam. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features. Human Pathology 2010; 41(7): 1009 doi: 10.1016/j.humpath.2009.11.014
|
| 25 |
Joe B. Harford, Sang-Soo Kim, Kathleen F. Pirollo, Antonina S. Rait, Esther H. Chang. Advanced Concepts and Strategies in Central Nervous System Tumors [Working Title]. 2024; doi: 10.5772/intechopen.1007332
|
| 26 |
Ming-Cheng Chen, Nien-Hung Lee, Tsung-Jung Ho, Hsi-Hsien Hsu, Chia-Hua Kuo, Wei-Wen Kuo, Yueh-Min Lin, Fuu-Jen Tsai, Chang-Hai Tsai, Chih-Yang Huang. Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells. Cancer Letters 2014; 349(1): 51 doi: 10.1016/j.canlet.2014.03.023
|
| 27 |
Takeshi Kinoshita, Hajime Higuchi, Ayano- Kabashima-, Gen Sakai, Yasuo Hamamoto, Hiromasa Takaishi, Takanori Kanai. Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture System. International Journal of Cancer Research 2017; 14(1): 1 doi: 10.3923/ijcr.2018.1.12
|
| 28 |
Qing Wen, Paul O'Reilly, Philip D Dunne, Mark Lawler, Sandra Van Schaeybroeck, Manuel Salto-Tellez, Peter Hamilton, Shu-Dong Zhang. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies. BMC Systems Biology 2015; 9(S5) doi: 10.1186/1752-0509-9-S5-S4
|
| 29 |
Xiuyan Yang, Jie Zhong, Qiufen Zhang, Li Feng, Zhen Zheng, Jian Zhang, Shaoyong Lu. Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.662579
|
| 30 |
Gregorio Bonazza, Stefano Tartaggia, Giuseppe Toffoli, Federico Polo, Salvatore Daniele. Voltammetric behaviour of the anticancer drug irinotecan and its metabolites in acetonitrile. Implications for electrochemical therapeutic drug monitoring. Electrochimica Acta 2018; 289: 483 doi: 10.1016/j.electacta.2018.09.094
|
| 31 |
Jing Zhao, Yixin Lu, Han-Ming Shen. Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Letters 2012; 314(1): 8 doi: 10.1016/j.canlet.2011.09.040
|
| 32 |
Pengfei Jiang, Rajesh Mukthavavam, Ying Chao, Ila Sri Bharati, Valentina Fogal, Sandra Pastorino, Xiuli Cong, Natsuko Nomura, Matt Gallagher, Taher Abbasi, Shireen Vali, Sandeep C Pingle, Milan Makale, Santosh Kesari. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-13
|
| 33 |
Christina V. Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz, Yawei Shen, Irina Ostrovnaya, Rodrigo Gularte-Mérida, Benjamin A. Nacev, Mark A. Dickson, Hakim Djaballah, Tomoyo Okada, Samuel Singer. A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma. Clinical Cancer Research 2022; 28(1): 175 doi: 10.1158/1078-0432.CCR-19-2486
|
| 34 |
ChunLei Li, JingXia Cui, CaiXia Wang, YanHui Li, Lan Zhang, Xian Xiu, YongFeng Li, Na Wei, Li Zhang, Ping Wang. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation. Journal of Pharmacy and Pharmacology 2011; 63(6): 765 doi: 10.1111/j.2042-7158.2011.01272.x
|
| 35 |
|
| 36 |
Sarah R. Mudd, Kimberley D. Holich, Martin J. Voorbach, Todd B. Cole, David R. Reuter, Paul Tapang, Gail Bukofzer, Arunava Chakravartty, Cherrie K. Donawho, Joann P. Palma, Gerard B. Fox, Mark Day, Yanping Luo. Pharmacodynamic Evaluation of Irinotecan Therapy by FDG and FLT PET/CT Imaging in a Colorectal Cancer Xenograft Model. Molecular Imaging and Biology 2012; 14(5): 617 doi: 10.1007/s11307-011-0529-8
|
| 37 |
Afraa Mamoori, Riajul Wahab, Jelena Vider, Vinod Gopalan, Alfred King-yin Lam. The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer. Gene 2019; 697: 165 doi: 10.1016/j.gene.2019.02.046
|
| 38 |
Alan J. Kim, David S. Hong, Goldy C. George. Dietary influences on symptomatic and non-symptomatic toxicities during cancer treatment: A narrative review. Cancer Treatment Reviews 2022; 108: 102408 doi: 10.1016/j.ctrv.2022.102408
|
| 39 |
Martina Tommasini, Elena Pellizzoni, Valentina Iacuzzi, Elena Marangon, Paola Posocco, Cristina Forzato, Paolo Bertoncin, Giuseppe Toffoli, Marina Resmini, Federico Berti. Fluorescent Imprinted Nanoparticles for the Effective Monitoring of Irinotecan in Human Plasma. Nanomaterials 2020; 10(9): 1707 doi: 10.3390/nano10091707
|
| 40 |
Yoichi Ozawa, Kazutomi Kusano, Takashi Owa, Akira Yokoi, Makoto Asada, Kentaro Yoshimatsu. Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment. Cancer Chemotherapy and Pharmacology 2012; 69(5): 1353 doi: 10.1007/s00280-012-1844-8
|
| 41 |
Young-Soon Na, Kyung-Ah Jung, Seung-Mi Kim, Yong Sang Hong, Min-Hee Ryu, Se Jin Jang, Dae Hyuk Moon, Dong-Hyung Cho, Jin Cheon Kim, Jung Shin Lee, Tae Won Kim. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. Cancer Chemotherapy and Pharmacology 2011; 68(2): 389 doi: 10.1007/s00280-010-1495-6
|
| 42 |
Carly Griffin, Aditya Karnik, James McNulty, Siyaram Pandey. Pancratistatin Selectively Targets Cancer Cell Mitochondria and Reduces Growth of Human Colon Tumor Xenografts. Molecular Cancer Therapeutics 2011; 10(1): 57 doi: 10.1158/1535-7163.MCT-10-0735
|